![Anthony DiGiandomenico](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony DiGiandomenico
Gründer bei
MDB CAPITAL HOLDINGS, LLC
Vermögen: 5 Mio $ am 31.05.2026
Profil
Anthony DiGiandomenico is the founder of Public Ventures LLC, founded in 1997, and MDB Capital Holdings LLC, founded in 1997, where the title held is Director & Chief Transactions.
Current jobs include Independent Director at ClearSign Technologies Corp.
starting in 2025; Director at Pier Acquisition I, Inc.; Director at Pier Acquisition II, Inc.; Independent Director at ENDRA Life Sciences, Inc. since 2013; Managing Director at National Association of Securities Dealers, Inc. since 1997; Independent Director at Illumination Acquisition Corp.
I starting in 2026; and Director at eXoZymes, Inc. since 2019.
Former jobs include President & Chief Executive Officer at Digian Co.; Director at Orion Acquisition Corp.
II; Director at Charlie's Holdings, Inc. from 2004 to 2012; Director at Cue Biopharma, Inc. from 2016 to 2019; and Independent Director at Provention Bio, Inc. from 2017 to 2020.
Education includes undergraduate studies at The University of Colorado and an MBA from Haas School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.09.2025 | 1’245’000 ( 24.9% ) | 4 Mio $ | 31.05.2026 | |
| 25.06.2026 | 76’267 ( 6% ) | 419 469 $ | 31.05.2026 | |
| 30.09.2025 | 80’693 ( 1.48% ) | 282 426 $ | 31.05.2026 | |
| 30.06.2026 | 54’447 ( 1.01% ) | 252 090 $ | 31.05.2026 | |
EXOZYMES INC. -.--% | 09.06.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Anthony DiGiandomenico
| Unternehmen | Position | Beginn |
|---|---|---|
| ENDRA LIFE SCIENCES INC. | Direktor/Vorstandsmitglied | 01.07.2013 |
| MDB CAPITAL HOLDINGS, LLC | Gründer | 01.01.1997 |
| EXOZYMES, INC. | Direktor/Vorstandsmitglied | 01.04.2019 |
| CLEARSIGN TECHNOLOGIES CORPORATION | Direktor/Vorstandsmitglied | 22.05.2025 |
Pier Acquisition I, Inc.
 Pier Acquisition I, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direktor/Vorstandsmitglied | 16.11.2009 |
Pier Acquisition II, Inc.
 Pier Acquisition II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direktor/Vorstandsmitglied | 16.11.2009 |
National Association of Securities Dealers, Inc.
 National Association of Securities Dealers, Inc. Investment Banks/BrokersFinance Provides financial regulatory services | Corporate Officer/Principal | 25.07.2011 |
Ehemalige bekannte Positionen von Anthony DiGiandomenico
| Unternehmen | Position | Ende |
|---|---|---|
| PROVENTION BIO, INC. | Direktor/Vorstandsmitglied | 19.05.2020 |
| CUE BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 03.10.2019 |
| ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░ | - |
Ausbildung von Anthony DiGiandomenico
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Orion Acquisition Corp. II
 Orion Acquisition Corp. II Financial ConglomeratesFinance Development stage company | Finance |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Charlies Holdings, Inc.
 Charlies Holdings, Inc. Industrial ConglomeratesProducer Manufacturing Manufactures and sells nicotine-based vapor products | Producer Manufacturing |
ClearSign Technologies Corp.
 ClearSign Technologies Corp. Industrial MachineryProducer Manufacturing Operates as a development stage company that designs and develops technologies for combustion systems | Producer Manufacturing |
Pier Acquisition I, Inc.
Pier Acquisition I, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Pier Acquisition II, Inc.
Pier Acquisition II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ENDRA Life Sciences, Inc.
 ENDRA Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical imaging technology solutions | Health Technology |
National Association of Securities Dealers, Inc.
National Association of Securities Dealers, Inc. Investment Banks/BrokersFinance Provides financial regulatory services | Finance |
Digian Co. | |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
MDB Capital Holdings LLC
 MDB Capital Holdings LLC Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and sells chemicals for pharmaceuticals, fuels, materials, food additives & novel compounds | Process Industries |
Wählen Sie MarketScreener 
